Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
Hydration problems often masquerade as medication side effects. Micronutrients to Watch Appetite suppression can worsen pre-existing nutrient gaps
Frequently asked questions Which fee catches the most people out
In this study, we were only able to include medicated patients, as recruitment of drug-nave patients was not possible
The Stampede and similar events create multi-day drinking environments, plan for complete abstinence during such events rather than trying to moderate
We understand that achieving your desired goals often involves more than just one approach